Mark James Litton

Mark James Litton has an estimated net worth of $6.25 Million. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, ALPINE IMMUNE SCIENCES, INC., and LeonaBio, Inc..

2024 was Mark James Litton's most active year for acquiring shares with 8 total transactions. Mark James Litton's most active month to acquire stocks was the month of December. 2016 was Mark James Litton's most active year for disposing of shares, totalling 16 transactions. Mark James Litton's most active month to dispose stocks was the month of December. 2021 saw Mark James Litton paying a total of $91,693.50 for 137,192 shares, this is the most they've acquired in one year. In 2015 Mark James Litton cashed out on 92,764 shares for a total of $2,148,960.83, their largest year based on trade value.